ORTHOPEDIATRICS CORP.

(KIDS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OrthoPediatrics Corp. Provides Preliminary Unaudited Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2021

01/10/2022 | 07:01am EDT

OrthoPediatrics Corp. provided preliminary unaudited revenue guidance for the fourth quarter and full year ended December 31, 2021. For the quarter, the company expects revenue to be $24.8 million, up 31%, compared to $18.9 million in the fourth quarter of 2020. For the full year, the company expects revenue to be $98.0 million, representing annual growth of 38%.


© S&P Capital IQ 2022
All news about ORTHOPEDIATRICS CORP.
05/24OrthoPediatrics to Participate in The JMP Securities Life Sciences Conference
GL
05/24OrthoPediatrics to Participate in The JMP Securities Life Sciences Conference
AQ
05/10ORTHOPEDIATRICS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
AQ
05/10OrthoPediatrics Corp. Continues Double Diamond Sponsorship for 2022 POSNA Meeting
GL
05/10OrthoPediatrics Corp. Continues Double Diamond Sponsorship for 2022 POSNA Meeting
AQ
05/06Piper Sandler Adjusts OrthoPediatrics' Price Target to $55 From $80, Reiterates Overwei..
MT
05/05ORTHOPEDIATRICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
05/05Needham Adjusts Price Target for OrthoPediatrics to $59 From $65, Maintains Buy Rating
MT
05/05TRANSCRIPT : OrthoPediatrics Corp., Q1 2022 Earnings Call, May 05, 2022
CI
05/04ORTHOPEDIATRICS : Q1 Earnings Snapshot
AQ
More news
Analyst Recommendations on ORTHOPEDIATRICS CORP.
More recommendations
Financials (USD)
Sales 2022 123 M - -
Net income 2022 -22,3 M - -
Net Debt 2022 - - -
P/E ratio 2022 -38,2x
Yield 2022 -
Capitalization 881 M 881 M -
Capi. / Sales 2022 7,19x
Capi. / Sales 2023 6,04x
Nbr of Employees 133
Free-Float 70,3%
Chart ORTHOPEDIATRICS CORP.
Duration : Period :
OrthoPediatrics Corp. Technical Analysis Chart | KIDS | US68752L1008 | MarketScreener
Technical analysis trends ORTHOPEDIATRICS CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 43,55 $
Average target price 61,17 $
Spread / Average Target 40,5%
EPS Revisions
Managers and Directors
David R. Bailey President, Chief Executive Officer & Director
Fred L. Hite Director, Chief Operating & Financial Officer
Mark C. Throdahl Executive Chairman
Peter F. Armstrong Chief Medical Officer
Joel Batts Senior Vice President-Science & Technology
Sector and Competitors
1st jan.Capi. (M$)
ORTHOPEDIATRICS CORP.-28.55%865
STRYKER CORPORATION-12.12%88 870
SMITH & NEPHEW PLC0.19%14 172
INSPIRE MEDICAL SYSTEMS, INC.-24.32%4 804
AXONICS, INC.-11.48%2 333
DOUBLE MEDICAL TECHNOLOGY INC.-33.88%2 086